Association of circulatory Tfh-like cells with neutralizing antibody responses among chronic HIV-1 subtype C infected long-Term nonprogressors and progressors

Chinnambedu Ravichandran Swathirajan, Pannerselvam Nandagopal, Ramachandran Vignesh, Aylur Kailasam Srikrishnan, Rajat Goyal, Huma Qureshi, Shanmugam Saravanan, Sunil Solomon, Luke Elizabeth Hanna, Munusamy Ponnan Sivasankaran, Nikhil Singla, Joyeeta Mukherjee, Shweta Chatrath, Jakub Kopycinski, Kailapuri Gangatharan Murugavel

Research output: Contribution to journalArticle

Abstract

HIV-1 vaccine functioning relies on successful induction of broadly neutralizing antibodies (bNAbs). CXCR3-circulatory T-follicular helper (cTfh) cells are necessary for inducing B-cells for generating bNAbs. Recent studies have suggested that CXCR3+ Tfh cells might also influence bNAb production. Plasma samples from 34 ART-Naïve HIV-1 infected individuals [long-Term nonprogressors (LTNP)-19; Progressors-13] were tested against a heterologous virus panel (n = 11) from subtypes A, B, C, G, AC, BC and AE. Frequencies of CXCR3+ and CXCR3-cTfh-like cells in peripheral circulation were studied using flow cytometry. LTNP showed significantly lower CXCR3+ and higher CXCR3-cTfh-like cell frequencies, while neutralization breadth was observed to be broader in progressors. A positive correlation was observed between bNAb breadth and potency with CXCR3+PD-1+ cTfh-like cells in LTNP. Based on neutralization breadth, 9 HIV-1 infected individuals were classified as 'top neutralizers' and 23 as 'low neutralizers' and they did not show any correlations with CXCR3+ and CXCR3-cTfh-like cells. These preliminary data suggest that CXCR3+ similar to CXCR3-might possess significant functional properties for driving B-cells to produce bNAbs. Hence, an HIV vaccine which is capable of optimal induction of CXCR3+ cTfh cells at germinal centers might confer superior protection against HIV.

Original languageEnglish (US)
Article numberftz044
JournalPathogens and Disease
Volume77
Issue number4
DOIs
StatePublished - Jan 1 2019

Fingerprint

Helper-Inducer T-Lymphocytes
Neutralizing Antibodies
Antibody Formation
HIV-1
AIDS Vaccines
B-Lymphocytes
Germinal Center
Flow Cytometry
HIV
Viruses

Keywords

  • broadly neutralizing antibodies
  • circulatory Tfh-like cells
  • HIV-1 neutralizers
  • MPER binding antibodies

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology and Microbiology(all)
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Association of circulatory Tfh-like cells with neutralizing antibody responses among chronic HIV-1 subtype C infected long-Term nonprogressors and progressors. / Swathirajan, Chinnambedu Ravichandran; Nandagopal, Pannerselvam; Vignesh, Ramachandran; Srikrishnan, Aylur Kailasam; Goyal, Rajat; Qureshi, Huma; Saravanan, Shanmugam; Solomon, Sunil; Hanna, Luke Elizabeth; Sivasankaran, Munusamy Ponnan; Singla, Nikhil; Mukherjee, Joyeeta; Chatrath, Shweta; Kopycinski, Jakub; Murugavel, Kailapuri Gangatharan.

In: Pathogens and Disease, Vol. 77, No. 4, ftz044, 01.01.2019.

Research output: Contribution to journalArticle

Swathirajan, CR, Nandagopal, P, Vignesh, R, Srikrishnan, AK, Goyal, R, Qureshi, H, Saravanan, S, Solomon, S, Hanna, LE, Sivasankaran, MP, Singla, N, Mukherjee, J, Chatrath, S, Kopycinski, J & Murugavel, KG 2019, 'Association of circulatory Tfh-like cells with neutralizing antibody responses among chronic HIV-1 subtype C infected long-Term nonprogressors and progressors', Pathogens and Disease, vol. 77, no. 4, ftz044. https://doi.org/10.1093/femspd/ftz044
Swathirajan, Chinnambedu Ravichandran ; Nandagopal, Pannerselvam ; Vignesh, Ramachandran ; Srikrishnan, Aylur Kailasam ; Goyal, Rajat ; Qureshi, Huma ; Saravanan, Shanmugam ; Solomon, Sunil ; Hanna, Luke Elizabeth ; Sivasankaran, Munusamy Ponnan ; Singla, Nikhil ; Mukherjee, Joyeeta ; Chatrath, Shweta ; Kopycinski, Jakub ; Murugavel, Kailapuri Gangatharan. / Association of circulatory Tfh-like cells with neutralizing antibody responses among chronic HIV-1 subtype C infected long-Term nonprogressors and progressors. In: Pathogens and Disease. 2019 ; Vol. 77, No. 4.
@article{3b65546a16cd4742814216749a55d1b9,
title = "Association of circulatory Tfh-like cells with neutralizing antibody responses among chronic HIV-1 subtype C infected long-Term nonprogressors and progressors",
abstract = "HIV-1 vaccine functioning relies on successful induction of broadly neutralizing antibodies (bNAbs). CXCR3-circulatory T-follicular helper (cTfh) cells are necessary for inducing B-cells for generating bNAbs. Recent studies have suggested that CXCR3+ Tfh cells might also influence bNAb production. Plasma samples from 34 ART-Na{\"i}ve HIV-1 infected individuals [long-Term nonprogressors (LTNP)-19; Progressors-13] were tested against a heterologous virus panel (n = 11) from subtypes A, B, C, G, AC, BC and AE. Frequencies of CXCR3+ and CXCR3-cTfh-like cells in peripheral circulation were studied using flow cytometry. LTNP showed significantly lower CXCR3+ and higher CXCR3-cTfh-like cell frequencies, while neutralization breadth was observed to be broader in progressors. A positive correlation was observed between bNAb breadth and potency with CXCR3+PD-1+ cTfh-like cells in LTNP. Based on neutralization breadth, 9 HIV-1 infected individuals were classified as 'top neutralizers' and 23 as 'low neutralizers' and they did not show any correlations with CXCR3+ and CXCR3-cTfh-like cells. These preliminary data suggest that CXCR3+ similar to CXCR3-might possess significant functional properties for driving B-cells to produce bNAbs. Hence, an HIV vaccine which is capable of optimal induction of CXCR3+ cTfh cells at germinal centers might confer superior protection against HIV.",
keywords = "broadly neutralizing antibodies, circulatory Tfh-like cells, HIV-1 neutralizers, MPER binding antibodies",
author = "Swathirajan, {Chinnambedu Ravichandran} and Pannerselvam Nandagopal and Ramachandran Vignesh and Srikrishnan, {Aylur Kailasam} and Rajat Goyal and Huma Qureshi and Shanmugam Saravanan and Sunil Solomon and Hanna, {Luke Elizabeth} and Sivasankaran, {Munusamy Ponnan} and Nikhil Singla and Joyeeta Mukherjee and Shweta Chatrath and Jakub Kopycinski and Murugavel, {Kailapuri Gangatharan}",
year = "2019",
month = "1",
day = "1",
doi = "10.1093/femspd/ftz044",
language = "English (US)",
volume = "77",
journal = "Pathogens and Disease",
issn = "2049-632X",
publisher = "John Wiley & Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Association of circulatory Tfh-like cells with neutralizing antibody responses among chronic HIV-1 subtype C infected long-Term nonprogressors and progressors

AU - Swathirajan, Chinnambedu Ravichandran

AU - Nandagopal, Pannerselvam

AU - Vignesh, Ramachandran

AU - Srikrishnan, Aylur Kailasam

AU - Goyal, Rajat

AU - Qureshi, Huma

AU - Saravanan, Shanmugam

AU - Solomon, Sunil

AU - Hanna, Luke Elizabeth

AU - Sivasankaran, Munusamy Ponnan

AU - Singla, Nikhil

AU - Mukherjee, Joyeeta

AU - Chatrath, Shweta

AU - Kopycinski, Jakub

AU - Murugavel, Kailapuri Gangatharan

PY - 2019/1/1

Y1 - 2019/1/1

N2 - HIV-1 vaccine functioning relies on successful induction of broadly neutralizing antibodies (bNAbs). CXCR3-circulatory T-follicular helper (cTfh) cells are necessary for inducing B-cells for generating bNAbs. Recent studies have suggested that CXCR3+ Tfh cells might also influence bNAb production. Plasma samples from 34 ART-Naïve HIV-1 infected individuals [long-Term nonprogressors (LTNP)-19; Progressors-13] were tested against a heterologous virus panel (n = 11) from subtypes A, B, C, G, AC, BC and AE. Frequencies of CXCR3+ and CXCR3-cTfh-like cells in peripheral circulation were studied using flow cytometry. LTNP showed significantly lower CXCR3+ and higher CXCR3-cTfh-like cell frequencies, while neutralization breadth was observed to be broader in progressors. A positive correlation was observed between bNAb breadth and potency with CXCR3+PD-1+ cTfh-like cells in LTNP. Based on neutralization breadth, 9 HIV-1 infected individuals were classified as 'top neutralizers' and 23 as 'low neutralizers' and they did not show any correlations with CXCR3+ and CXCR3-cTfh-like cells. These preliminary data suggest that CXCR3+ similar to CXCR3-might possess significant functional properties for driving B-cells to produce bNAbs. Hence, an HIV vaccine which is capable of optimal induction of CXCR3+ cTfh cells at germinal centers might confer superior protection against HIV.

AB - HIV-1 vaccine functioning relies on successful induction of broadly neutralizing antibodies (bNAbs). CXCR3-circulatory T-follicular helper (cTfh) cells are necessary for inducing B-cells for generating bNAbs. Recent studies have suggested that CXCR3+ Tfh cells might also influence bNAb production. Plasma samples from 34 ART-Naïve HIV-1 infected individuals [long-Term nonprogressors (LTNP)-19; Progressors-13] were tested against a heterologous virus panel (n = 11) from subtypes A, B, C, G, AC, BC and AE. Frequencies of CXCR3+ and CXCR3-cTfh-like cells in peripheral circulation were studied using flow cytometry. LTNP showed significantly lower CXCR3+ and higher CXCR3-cTfh-like cell frequencies, while neutralization breadth was observed to be broader in progressors. A positive correlation was observed between bNAb breadth and potency with CXCR3+PD-1+ cTfh-like cells in LTNP. Based on neutralization breadth, 9 HIV-1 infected individuals were classified as 'top neutralizers' and 23 as 'low neutralizers' and they did not show any correlations with CXCR3+ and CXCR3-cTfh-like cells. These preliminary data suggest that CXCR3+ similar to CXCR3-might possess significant functional properties for driving B-cells to produce bNAbs. Hence, an HIV vaccine which is capable of optimal induction of CXCR3+ cTfh cells at germinal centers might confer superior protection against HIV.

KW - broadly neutralizing antibodies

KW - circulatory Tfh-like cells

KW - HIV-1 neutralizers

KW - MPER binding antibodies

UR - http://www.scopus.com/inward/record.url?scp=85072040861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072040861&partnerID=8YFLogxK

U2 - 10.1093/femspd/ftz044

DO - 10.1093/femspd/ftz044

M3 - Article

VL - 77

JO - Pathogens and Disease

JF - Pathogens and Disease

SN - 2049-632X

IS - 4

M1 - ftz044

ER -